- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
953
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
953 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A335890 | ₩8,880.00 | -2.4% | 28.0% | ₩512.8b | ₩13,666.67 | PE35.9x | E28.1% | 0.2% | Healthcare | ||
EXL1V | €0.39 | 3.2% | -88.3% | €41.8m | n/a | PB1.1x | E69.0% | n/a | Capital Goods | ||
861 | HK$2.95 | -10.3% | 18.5% | HK$5.0b | HK$4.50 | PB0.7x | E61.8% | 2.4% | Software | ||
AIM | AU$0.71 | -5.3% | 136.7% | AU$143.0m | n/a | PS2.2x | E77.0% | n/a | Commercial Services | ||
GXI | €96.90 | -4.8% | -3.1% | €3.3b | €131.12 | PE29x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
DTH | €3.52 | 1.7% | -8.8% | €89.9m | €4.90 | PE26.2x | E22.4% | n/a | Commercial Services | ||
SINCH | SEK 32.26 | -0.2% | 74.0% | SEK 27.2b | SEK 35.19 | PE138.9x | E48.5% | n/a | Software | ||
9926 | HK$67.40 | 2.9% | 87.2% | HK$55.4b | HK$65.80 | PS28.1x | E54.5% | n/a | Pharmaceuticals & Biotech | ||
300019 | CN¥12.42 | 14.5% | -22.7% | CN¥4.6b | CN¥18.20 | PE17.2x | E28.5% | 2.4% | Materials | ||
603997 | CN¥12.75 | 10.9% | -13.5% | CN¥15.7b | CN¥14.61 | PE92.2x | E73.2% | 0% | Automobiles | ||
3994 | JP¥5,976.00 | 2.2% | 24.4% | JP¥322.4b | JP¥7,011.11 | PS9x | E68.1% | n/a | Software | ||
NHY | NOK 67.18 | 7.1% | 2.6% | NOK 134.0b | NOK 77.21 | PE701.7x | E47.8% | 3.7% | Materials | ||
VESBE | ₺17.64 | -1.3% | 5.6% | ₺28.2b | ₺30.07 | PE8x | E38.5% | 4.1% | Consumer Durables | ||
SECU B | SEK 130.55 | 2.7% | 55.9% | SEK 74.8b | SEK 121.83 | PE49.3x | E41.3% | 2.9% | Commercial Services | ||
CCC | SEK 21.00 | 6.6% | 43.8% | SEK 2.2b | n/a | PE54.5x | E27.9% | 0% | Capital Goods | ||
603505 | CN¥27.93 | 21.2% | -5.6% | CN¥16.3b | CN¥29.00 | PE43.1x | E30.7% | 1.1% | Materials | ||
541974 | ₹840.90 | 7.5% | 104.3% | ₹47.9b | n/a | PE119.1x | E39.0% | 0.05% | Food, Beverage & Tobacco | ||
688046 | CN¥12.71 | 14.4% | -26.1% | CN¥4.8b | CN¥16.71 | PE32.9x | E24.6% | 0.5% | Pharmaceuticals & Biotech | ||
FXPO | UK£0.48 | 15.2% | -36.1% | UK£282.4m | n/a | PB0.4x | E70.8% | 0% | Materials | ||
EVTC | US$33.21 | -2.1% | -10.9% | US$2.1b | US$37.40 | PE30.6x | E21.4% | 0.6% | Diversified Financials | ||
BIOT | SEK 184.40 | 1.2% | 74.8% | SEK 14.8b | SEK 193.33 | PE58.8x | E20.4% | 0.9% | Pharmaceuticals & Biotech | ||
RYM | NZ$4.27 | -4.0% | -32.3% | NZ$3.0b | NZ$6.25 | PE612.7x | E23.5% | 0% | Healthcare | ||
MBR | zł295.00 | -1.0% | 12.6% | zł1.0b | zł372.31 | PE15.1x | E22.9% | 4.5% | Commercial Services | ||
BST | €1.45 | -1.2% | 31.0% | €116.7m | €2.07 | PB0.4x | E24.9% | 4.5% | Banks |